Table II.
Patient demographics, comorbidities, disposition and their association with mortality rate
| All patients |
Outcomes |
||||
|---|---|---|---|---|---|
| No. (%) | HD failure, % | Mortality, % | Permanent catheterization, % | Renal recovery, % | |
| Total, n (%) | 48 (100) | 15 (31.3) | 34 (70.8) | 7 (14.6) | 6 (12.5) |
| Treatment | |||||
| Heparin locking | 37 (77.1) | 24.3a | 64.9a | 16.2 | 16.2 |
| Systemic anticoagulation | 22 (45.8) | 45.5a | 81.8 | 9.1 | 9.1 |
| Increased VTE prophylaxis | 15 (31.3) | 33.3 | 66.7 | 13.3 | 20.0 |
| Demographics | |||||
| Age > 65 | 17 (35.4) | 17.7 | 76.5 | 11.8 | 5.9 |
| Female sex | 23 (47.9) | 26.1 | 60.9 | 17.4 | 17.4 |
| Comorbidities | |||||
| DM | 24 (50.0) | 37.5 | 83.3a | 8.3 | 8.3 |
| BMI > 40 | 18 (37.5) | 33.3 | 72.2 | 16.7 | 11.1 |
| CKD | 10 (20.8) | 40.0 | 60.0 | 30.0 | 0.0 |
| ESRD | 6 (12.5) | 16.7 | 66.7 | 16.7 | 16.7 |
| HTN | 34 (70.8) | 32.4 | 70.6 | 14.7 | 14.7 |
| COPD | 4 (8.3) | 50.0 | 75.0 | 0.0 | 25.0 |
| Prehospital anticoagulation | 17 (35.4) | 29.4 | 64.7 | 17.7 | 17.7 |
| Catheter location | |||||
| Right IJ | 13 (27.1) | 15.4 | 69.2 | 15.4 | 15.4 |
| Left IJ | 7 (14.6) | 28.6 | 57.1 | 28.6 | 14.3 |
| Right femoral | 21 (43.8) | 42.9 | 76.2 | 0.0 | 14.3 |
| Left femoral | 7 (14.6) | 28.6 | 71.4 | 14.3 | 9.5 |
| Catheter length | |||||
| 16 cm double lumen | 9 (18.8) | 11.1 | 66.7 | 22.2 | 11.1 |
| 16 cm triple lumen | 7 (14.6) | 28.6 | 71.4 | 14.3 | 14.3 |
| 20 cm double lumen | 8 (16.7) | 25.0 | 75.0 | 12.5 | 12.5 |
| 24 cm double lumen | 24 (50.0) | 41.7 | 70.8 | 12.5 | 12.5 |
BMI, Body mass index; CKD, chronic kidney disease; COPD, chronic obstructive pulmonary disease; DM, diabetes mellitus; ESRD, end-stage renal disease; HTN, hypertension; IJ, internal jugular vein; VTE, venous thromboembolism.One patient was discharged to hospice and therefore was not included in the outcome data. Significance values represent results of χ2 testing for the predictor group by outcome status. Percentages in outcome columns represent the percent of patients in the predictor group with the corresponding outcome.
a
P < .10.